Penumbra Inc (PEN) - Total Assets
Based on the latest financial reports, Penumbra Inc (PEN) holds total assets worth $1.90 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Penumbra Inc (PEN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Penumbra Inc - Total Assets Trend (2013–2025)
This chart illustrates how Penumbra Inc's total assets have evolved over time, based on quarterly financial data. See Penumbra Inc book value and equity for net asset value and shareholders' equity analysis.
Penumbra Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Penumbra Inc's total assets of $1.90 Billion consist of 66.6% current assets and 33.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $186.90 Million | 10.2% |
| Accounts Receivable | $190.02 Million | 10.4% |
| Inventory | $431.55 Million | 23.6% |
| Property, Plant & Equipment | $317.00 Million | 17.4% |
| Intangible Assets | $6.19 Million | 0.3% |
| Goodwill | $166.75 Million | 9.1% |
Asset Composition Trend (2013–2025)
This chart illustrates how Penumbra Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PEN company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Penumbra Inc's current assets represent 66.6% of total assets in 2025, a decrease from 87.5% in 2013.
- Cash Position: Cash and equivalents constituted 10.2% of total assets in 2025, up from 5.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 23.6% of total assets.
Penumbra Inc Competitors by Total Assets
Key competitors of Penumbra Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SIEMENS HEALTH ADR/050
F:SHL1
|
Germany | €44.27 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
|
Somnomed Ltd
AU:SOM
|
Australia | AU$79.90 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
|
Promimic AB
ST:PRO
|
Sweden | Skr75.71 Million |
Penumbra Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.02 | 6.30 | 6.04 |
| Quick Ratio | 3.95 | 3.68 | 3.68 |
| Cash Ratio | 0.00 | 2.37 | 0.76 |
| Working Capital | $1.06 Billion | $841.08 Million | $545.07 Million |
Penumbra Inc - Advanced Valuation Insights
This section examines the relationship between Penumbra Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.57 |
| Latest Market Cap to Assets Ratio | 6.90 |
| Asset Growth Rate (YoY) | 19.1% |
| Total Assets | $1.83 Billion |
| Market Capitalization | $12.60 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Penumbra Inc's assets at a significant premium (6.90x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Penumbra Inc's assets grew by 19.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Penumbra Inc (2013–2025)
The table below shows the annual total assets of Penumbra Inc from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $1.83 Billion | +19.13% |
| 2024-12-31 | $1.53 Billion | -1.49% |
| 2023-12-31 | $1.56 Billion | +13.53% |
| 2022-12-31 | $1.37 Billion | +10.18% |
| 2021-12-31 | $1.24 Billion | +51.19% |
| 2020-12-31 | $822.98 Million | +23.59% |
| 2019-12-31 | $665.90 Million | +29.30% |
| 2018-12-31 | $515.01 Million | +8.04% |
| 2017-12-31 | $476.67 Million | +54.63% |
| 2016-12-31 | $308.25 Million | +16.83% |
| 2015-12-31 | $263.85 Million | +117.37% |
| 2014-12-31 | $121.38 Million | +70.61% |
| 2013-12-31 | $71.15 Million | -- |
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more